(19)
(11) EP 4 558 156 A1

(12)

(43) Date of publication:
28.05.2025 Bulletin 2025/22

(21) Application number: 23750758.7

(22) Date of filing: 21.07.2023
(51) International Patent Classification (IPC): 
A61K 36/07(2006.01)
A61K 36/06(2006.01)
 A61P 19/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 36/07; A61K 36/06
(86) International application number:
PCT/IB2023/057469
(87) International publication number:
WO 2024/018437 (25.01.2024 Gazette 2024/04)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 21.07.2022 IT 202200015375

(71) Applicant: Vivatis Pharma Italia S.R.L.
21013 Gallarate (VA) (IT)

(72) Inventors:
  • CERANA, Giorgio Stefano
    21013 Gallarate (VA) (IT)
  • BOS, Peter
    21013 Gallarate (VA) (IT)

(74) Representative: Marben S.r.l. 
Via Larga, 16
20122 Milano
20122 Milano (IT)

   


(54) A NEW HIGH MOLECULAR WEIGHT OF HYALURONIC ACID OR SALT THEREOF OF PLANT ORIGIN FOR USE IN MAINTAINING JOINT HOMEOSTASIS AND PREVENTING THE HARMFUL PROCESSES OF OSTEOARTHRITIS